cancer support & treatment

What is the Metabolic Approach to Cancer?

In very simple terms, the metabolic approach to cancer is a methodology in which we leverage a metabolic state that weakens cancer cells while simultaneously improving the overall milieu of healthy cells and immune modulation. In addition, the metabolic approach aims to discover any contributing underlying factors and deal with them, if possible.

MATC-trained doctors acknowledge and understand that every person dealing with cancer has a unique set of contributing factors and circumstances related to their health and diagnosis. This is why putting people on a pre-determined protocol for a particular tumor type tends to fail the patient.

MATC-certified doctors understand:

The importance of putting the patient first in cancer care
The methodology, Test, Assess, Address™, for reversing chronic disease and managing cancer symptoms

An integrative approach combining standard of care, naturopathic medicine, and complementary therapies
How to improve outcomes, quality of life, and eventually, prevent cancer all together

The Metabolic Approach to Cancer requires thorough testing and assessment, so patients can be addressed properly. Continuous reassessment is necessary to understanding how a person is responding and generally progressing in their health journey. Anyone embarking on this path should be willing to take a realistic look at their diet, lifestyle, circadian rhythm, stressors and history. The Terrain Ten. (TM) Assessment of Genetics and Epigenetics, Blood Sugar Balance, Toxic Burden, Microbiome and Digestive Function, Immune Function, Inflammation, Blood Circulation and Angiogenesis, Hormone Balance, Stress and Biorhythms and Mental and Emotional Health are analyzed with every patient.

8-Week On-Boarding Metabolic Approach to Cancer Consulting Package : $1,775.00

On-Boarding assessment and initial management of New MATC patients is a 2-month process. The 8-week consulting package includes initial chart and lab review, a thorough, 90-minute first consultation, follow-up lab and progress review, and three 45-minute follow-up consultations with the doctor.

Bloodwork Analysis is conducted before your first visit and four weeks into your plan. For active cancering patients, lab review is recommended every 4-6 weeks. If you have a qualifying PPO insurance and you are based in Hawaii, we will run your labs at a local Diagnostic or Clinical Laboratory. If you do not live in Hawaii or do not have a qualifying insurance, we will run labs out-of-pocket, through a local lab or a third party lab that offers cash pay discounts. Any out-of-pocket costs for bloodwork are not included in the 8-week consulting package.

Integrative therapies, including IV therapy, nutraceutical and herbal prescriptions, oxygen therapies, mistletoe and therapeutic exercise, are at an additional cost not included in the consulting package.

Because of the complexity, time and energy required to assess and address a new patient dealing with cancer, a 2-month commitment and support package is required. We do not see new cancer patients for a one-time consult. If you are already being regularly supported by another MATC certified doctor, we can work with your provider for any additional care locally.

For the consultation package, if you have a PPO-qualifying insurance program, you may be able to get reimbursed by your insurance provider. If so, we will create insurance-formatted receipts for

What to Expect:

Weeks 1-2: On-boarding Assessment

Baseline assessment starts with an online self-assessment questionnaire, a thorough intake form, chart review and on-boarding lab analysis. Pathology and imaging reports will be reviewed by the doctor prior to your first visit. MATC On-boarding labs are collected and reviewed prior to your first doctor visit. Outside-the-box testing, including genetic SNP testing, blood biopsy testing and organic acids testing is encouraged, but not required. Ordering and reviewing labs, reviewing intake forms and history takes approximately one to two weeks. The doctor spends an average of three to five hours reviewing new patient data before seeing the patient in person. While the doctor is reviewing your data, you will begin educating yourself by reading or listening to The Metabolic Approach to Cancer, if you haven’t already. During this time, order and start using the keto mojo testing device.

Order extra lancets and testing strips as you will be testing multiple times a day to understand your current metabolic flexibility status. Watch the “HOW TO” videos on the keto mojo website. You will be journaling your diet, glucose and ketone readings right away.

Once the doctor has received and reviewed all of your data, you will be scheduled for your first doctor consultation. An action plan of therapeutic dietary intervention, lifestyle changes, nutraceutical and botanical prescriptions and other integrative therapies will be prescribed. Any additional assessment needed will be discussed. Additional therapies recommended may include mistletoe therapy, local regional hyperthermia, oxygen therapies, IV therapies, compounded medications and therapeutic exercise.
Weeks 2-6

Over the next 4 weeks, you will be 100% implementing your metabolic lifestyle plan. One to two weeks into plan implementation, you will have a follow-up consultation with the doctor to track progress and address any questions or concerns You will be logging your diet, glucose, ketones and activity, which the doctor will be reviewing prior to your follow-up visit. You may be coming into the clinic for regular treatments, like local regional hyperthermia, IV therapy, oxygen and exercise. Treatments may be administered by doctors, nurses or medical assistants, depending on the prescription.

After 4 weeks of plan implementation, MATC lab analysis is repeated. You will meet with the doctor on week 5 or 6, after your second round of lab results are in, for your third doctor consultation. The doctor will review your lab results and progress reports prior to your visit. Any adjustments to plan are discussed and implemented.
Weeks 7-8

Local Regional Hyperthermia with Thermofield

Thermofield Hyperthermia is a groundbreaking medical device with enormous potential to improve cancer treatment. By sending large amounts of electromagnetic energy deep into targeted tissue, it can safely elevate tumor temperatures to levels above 114 degrees Fahrenheit, the heat level shown in peer-reviewed research to destroy cancer cells and stimulate a significant increase in heat shock proteins. Cancer cells have dysfunctional metabolism and cannot dispel heat the way our healthy cells can, so they compound heat, weakening them and creating a surge in heat shock proteins. The surge in extracellular heat shock proteins stimulates the immune system to launch a persistent attack against the tumor.

Uses of Local Hyperthermia with Thermofield include :

Adjunctive Cancer Treatment
Reducing pain
Treating Benign Prostatic Hypertrophy
Pelvic Floor/Vaginal/urogenital rejuvenation

How Does Targeted Hyperthermia Benefit Cancer Treatment?

Triggers the immune system to recognize and fight cancer
Alters the tumor microenvironment making cancer cells more vulnerable to all therapies, integrative and standard of care.
Improves Chemotherapy Efficacy up to 500%, improves radiation efficacy up to 300%

Induces Cancer Cell Apoptosis (cell death)
Reduces cancer pain by reducing pressure on adjacent nerve tissue
Reduces drug resistance, has been shown to reverse drug resistance
Shrinks tumors making them easier to remove surgically

Treatment

Treatments tend to be well tolerated and comfortable, lasting 45 minutes for cancer treatment.

A typical treatment regimen is 2-3 x a week for 2 months or longer. Ideally, synergistic anti-cancer treatments are given during or immediately after the hyperthermia treatment.

Hyperthermia has proven synergistic with:

Mistletoe Therapy
IV Vitamin C
HBOT
Quercetin

Photodynamic Therapy
Radiation
Chemotherapy
Immunotherapy

The Thermofield is not yet FDA approved for the treatment of any condition. There are no guarantees of benefit or treatment response.

Hannon, Gary & Tansi, Felista & Hilger, Ingrid & Prina-Mello, Adriele. (2021). The Effects of Localized Heat on the Hallmarks of Cancer. Advanced Therapeutics. 2000267. 10.1002/adtp.202000267. https://onlinelibrary.wiley.com/doi/pdf/10.1002/adtp.202000267

Why Use Oxygen Therapies in Cancer?

In our HEALTHY or injured, NON-cancerous cells, optimizing oxygen can enhance cellular health and repair. In CANCER cells, oxygenating has the OPPOSITE effect, reducing it’s growth and potential.

In CANCER cells, a LOW oxygen or hypoxic environment ENHANCES tumor growth and metabolism. Flooding the tumor environment with oxygen has been shown to DECREASE tumor cell survival, angiogenesis and metastasis. Increased oxygen in the tumor environment has been shown to alter gene expression to a LESS tumorigenic metabolism.

Some of the Known Mechanisms of Oxygen Therapy Suppressing Cancer include:

1. Lowers HIF-1. (Hypoxia Induction Factor)

2. Lowers Epithelial Mesenchymal Transition (EMT)

3. Lowers N-cadherin

4. Lowers Receptor Tyrosine Kinase AXL expression

5. Lowers VEGF (Vasoendothelial Growth Factor)

6. Increases Apoptosis

References:

www.consultdranderson.com

Moen I, Stuhr LE. Hyperbaric oxygen therapy and cancer–a review. Target Oncol. 2012 Dec;7(4):233-42.

doi: 10.1007/s11523-012-0233-x. Epub 2012 Oct 2. PMID: 23054400; PMCID: PMC3510426.

Moen I, Tronstad KJ, Kolmannskog O, Salvesen GS, Reed RK, Stuhr LE. Hyperoxia increases the uptake

of 5-fluorouracil in mammary tumors independently of changes in interstitial fluid pressure and tumor

stroma. BMC Cancer. 2009 Dec 17;9:446. doi: 10.1186/1471-2407-9-446. PMID: 20017908; PMCID:

PMC2805681

Stępień K, Ostrowski RP, Matyja E. Hyperbaric oxygen as an adjunctive therapy in treatment of malignancies, including brain tumours. Med Oncol. 2016 Sep;33(9):101. doi: 10.1007/s12032-016-0814-0. Epub 2016 Aug 2. PMID: 27485098; PMCID: PMC4971045.